Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Machat

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2003
Cabergoline versus levodopa monotherapy: a decision analysisAntje M Smala, E Annika Spottke, Olaf Machat, et al.
Pharmacoeconomics|August 16, 2005
Cost of illness and its predictors for Parkinson's disease in GermanyAnnika E Spottke, Martin Reuter, Olaf Machat, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2003
Cabergoline versus levodopa monotherapy: a decision analysisAntje M Smala, E Annika Spottke, Olaf Machat, et al.
Pharmacoeconomics|August 16, 2005
Cost of illness and its predictors for Parkinson's disease in GermanyAnnika E Spottke, Martin Reuter, Olaf Machat, et al.
Pageof 1